Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Early balding may be a sign of future prostate problems.

Suppressing certain hormones might help prevent prostate cancer.

Early baldness in men may indicate a higher risk of prostate cancer.

Early hair loss may indicate future prostate issues.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Analog 23 is a promising compound for prostate cancer treatment.

Finasteride may help prevent prostate cancer.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Targeting FGF5 could help treat prostate cancer.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Vertex pattern hair loss linked to higher prostate cancer risk.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Certain genetic markers can indicate a person's risk of developing prostate cancer.